Harmony Biosciences (HRMY) EBITDA (2019 - 2026)
Harmony Biosciences (HRMY) EBITDA from Sep 30, 2019 to Mar 31, 2026. The TTM Harmony Biosciences (HRMY) EBITDA is $211M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Harmony Biosciences (HRMY) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +8.00% |
| 3 Years TTM | +16.45% |
| 5 Years TTM | +38.37% |
Annual EBITDA change of Harmony Biosciences (HRMY)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $37M | -83.76% |
| 2025 | $230M | +20.21% |
| 2024 | $191M | -0.75% |
| 2023 | $193M | +59.64% |
| 2022 | $121M | +37.15% |
| 2021 | $88M | +405.98% |
| 2020 | $17M | -111.94% |
| 2019 | -$146M | N/A |
Comparison Harmony Biosciences (HRMY) five years EBITDA CAGR with competitors
Harmony Biosciences (HRMY) five years EBITDA CAGR is 45.75%.